Related Experiment Videos
Perioperative analgesia with subarachnoid sufentanil administration
M A Courtney1, A M Bader, B Hartwell
1Brigham and Women's Hospital, Boston, MA 02115.
Regional Anesthesia
|September 1, 1992
Summary
Subarachnoid sufentanil significantly prolonged analgesia duration in cesarean delivery patients. While pruritus increased, there was no observed respiratory depression or negative impact on neonatal outcomes.
Area of Science:
- Anesthesiology
- Obstetrics
- Pharmacology
Background:
- Elective cesarean delivery is a common surgical procedure.
- Effective pain management is crucial for maternal and neonatal well-being post-cesarean delivery.
- Subarachnoid anesthesia is frequently used for cesarean deliveries.
Purpose of the Study:
- To evaluate the effects of subarachnoid sufentanil administration in parturients undergoing elective cesarean delivery.
- To determine the optimal dosage of sufentanil for prolonged analgesia.
- To assess the safety and side effect profile of subarachnoid sufentanil.
Main Methods:
- Randomized, double-blind study involving 37 ASA Physical Status I parturients.
- Patients received bupivacaine with varying doses of sufentanil (10, 15, or 20 micrograms) or saline control.
- Evaluated sensory/motor block, analgesia duration, opioid requirements, and side effects (respiratory depression, pruritus, nausea, vomiting).
Main Results:
- Subarachnoid sufentanil significantly prolonged complete and effective analgesia duration compared to controls.
- Increased incidence of pruritus was observed with sufentanil administration.
- No significant differences in Apgar scores, blood gases, or neonatal neurobehavioral outcomes were noted among groups.
Conclusions:
- Subarachnoid sufentanil is effective in prolonging analgesia after cesarean delivery.
- Sufentanil administration did not adversely affect neonatal outcomes.
- Pruritus is a notable side effect requiring consideration in clinical practice.